Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 335

ProMIS Neurosciences to Participate in the Think Equity Investor Conference

Posted by fidest press agency su mercoledì, 24 aprile 2019

TORONTO and CAMBRIDGE, Mass., April 23, 2019 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced that it will participate in the Think Equity Investor Conference being held on May 2, 2019 at the Mandarin Oriental Hotel in New York.Eugene Williams, ProMIS’ Executive Chairman will provide overviews of its novel drug discovery and development programs for Alzheimer’s disease, Parkinson’s disease and ALS (amyotrophic lateral sclerosis) at 10:30 am ET, in the Lotus West Room. In his talk Mr. Williams will also underline how the evaluation of novel biomarkers in patients will significantly accelerate drug development in neurodegenerative diseases. The video webcast and slides of Mr. Williams’ presentation will be available through the following link The webcast will be archived for 90 days following the event through the same link.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: